CD20 peptides elicit a protective anti -tumor immune response in vivo

被引：0
|
作者：
Teillaud, Jean-Luc [1 ,2 ,3 ,4 ]
Riller, Quentin [1 ,2 ,4 ]
Siberil, Sophie [1 ,2 ,4 ]
机构：
[1] INSERM, UMRS 1138, Paris, France
[2] Cordeliers Res Ctr, Paris, France
[3] Univ Paris 05, Paris, France
[4] Univ Paris 06, Paris, France
来源：
JOURNAL OF IMMUNOLOGY | 2015年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
VAC5P.1126
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ADULT STILL'S DISEASE REFRACTORY TO TNFα AND ANTI ANTI CD20
    Yucra, D.
    Paris, V
    Parra, M.
    Beron, A.
    Curti, A.
    Dubinsky, D.
    Nasswetter, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S91 - S92
  • [22] Vaccination with CD20 peptide conjugates induces a biologically active, specific immune response in mice.
    Roberts, WK
    Agus, D
    Pinilla-Ibarz, J
    Zelenetz, A
    Livingston, PO
    Scheinberg, DA
    BLOOD, 2000, 96 (11) : 338A - 338A
  • [23] In vivo model of novel CD20 suicide gene system.
    Introna, M
    Di Gaetano, N
    Cittera, E
    Golay, J
    BLOOD, 2001, 98 (11) : 421A - 421A
  • [24] Inappropriate expression of CD40 ligand can elicit anti-self immune response
    Nakajima, A
    Morimoto, S
    Yoshino, S
    Yagita, H
    Okumura, K
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 608 - 608
  • [25] Two structurally different peptides mimic a CD20 epitope recognized by rituximab
    Perosa, F.
    Favoino, E.
    Vicenti, C.
    Prete, M.
    Dammacco, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 : A50 - A50
  • [26] Biomimetic Antigenic Nanoparticles Elicit Controlled Protective Immune Response to Influenza
    Patterson, Dustin P.
    Rynda-Apple, Agnieszka
    Harmsen, Ann L.
    Harmsen, Allen G.
    Douglas, Trevor
    ACS NANO, 2013, 7 (04) : 3036 - 3044
  • [27] Anti-tumor monoclonal antibodies: new insights to elicit a long-term immune response
    Deligne, Claire
    Gros, Laurent
    M S-MEDECINE SCIENCES, 2020, 35 (12): : 982 - 989
  • [28] Rituxan™:: Anti CD20 monoclonal antibody for the treatment of lymphoma.
    Grillo-López, AJ
    White, CA
    Dallaire, BK
    Varns, C
    Shen, D
    McClure, A
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 746 - 746
  • [29] Overcoming the resistance to the anti CD20 treatments in chronic lymphocytic leukaemia
    Scialdone, Annarita
    Damm, Jesper Kofoed
    Gullberg, Urban
    Drott, Kristina
    CANCER RESEARCH, 2016, 76
  • [30] MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB
    Rice, Ceara
    Ghandi-Das, Dhivya
    Negi, Anurag
    RHEUMATOLOGY, 2020, 59 : 94 - 94
12345